The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...

A dysfunctional signaling pathway in the hippocampus has been linked to chronic pain-related memory impairment in mice.

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

A common genetic pathway may account for increased risk for atherosclerotic disease in patients with chronic widespread musculoskeletal pain.

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...

"The burden of chronic pain is massive. Having objective biomarkers would greatly assist with decision making in the diagnosis, prevention and treatment of chronic pain," said senior author and ...